Latest / EMJ Podcast: Insights For Healthcare Professionals
AMJ Podcast | Episode 9 | Win Ratio in COPD: A New Lens on Trial Endpoints
This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. The content contained in this program was jointly developed by AMJ, the speakers, and Sanofi and Regeneron, and is not eligible for continuing medical education (CME) credits. The speakers were compensated by Sanofi and Regeneron in connection with this program.
COPD trial outcomes are not all equal, yet conventional endpoints can make it difficult to weigh severe events, exacerbations, lung function, and symptom burden within a single clinical picture.
In this AMJ podcast, Sanjay Ramakrishnan and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.